The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Anyone in PDL or MDX or BMS trials at Sloans in NYC?

angec
angec CSN Member Posts: 924 Member
in Kidney Cancer #1
Hello, i am looking for anyone currently in a trial there for this drug. I am hard pressed to find any information and having trouble getting an appt. to get in. Can anyone share any details with me? Thanking you in advance.

Angela
Like Care

Comments

  • Texas_wedge
    Texas_wedge CSN Member Posts: 2,798
    #2
    Trials at MSKCC
    Ange, I hope I am alive sees this - she is in a current trial there (targeted therapies, not immuno) and probably has a good idea of what's going on there.
    Like Care
  • angec
    angec CSN Member Posts: 924 Member
    #3
    Texas_wedge said:

    Trials at MSKCC
    Ange, I hope I am alive sees this - she is in a current trial there (targeted therapies, not immuno) and probably has a good idea of what's going on there.

    Thank you TW. Hope you are
    Thank you TW. Hope you are doing ok.
    Like Care
  • I am alive
    I am alive CSN Member Posts: 315
    #4
    Angela,
    I do know that
    Angela,
    I do know that Sloan is overseeing a phase 3 trial of BMS-936558 versus everolimus for RCC patients whose cancers persist despite prior treatment with an anti-angiogenic therapy (bevacizumab, sunitinib, pazopanib, axitinib or tivozanib). Patients in the trial are randomly given BMS or everolimus, but not both. To be eligible you cannot have more than 3 prior treatments, or any prior treatment with an mTOR or PD1 inhibitor. But alas, I do not know anyone in this trial so I can't tell you more about it. I do not know enough about trials in general - I'm barely 10 weeks into my first experience in a trial - to offer advice. Can your onc open a door there? I'm on a sharp learning curve here. Good luck!
    Like Care

Discussion Boards